Correlation Between Coya Therapeutics, and Mustang Bio
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Mustang Bio, you can compare the effects of market volatilities on Coya Therapeutics, and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Mustang Bio.
Diversification Opportunities for Coya Therapeutics, and Mustang Bio
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Coya and Mustang is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Mustang Bio go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Mustang Bio
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 0.97 times more return on investment than Mustang Bio. However, Coya Therapeutics, Common is 1.03 times less risky than Mustang Bio. It trades about 0.03 of its potential returns per unit of risk. Mustang Bio is currently generating about -0.07 per unit of risk. If you would invest 601.00 in Coya Therapeutics, Common on September 6, 2024 and sell it today you would earn a total of 8.00 from holding Coya Therapeutics, Common or generate 1.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Coya Therapeutics, Common vs. Mustang Bio
Performance |
Timeline |
Coya Therapeutics, Common |
Mustang Bio |
Coya Therapeutics, and Mustang Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Coya Therapeutics, and Mustang Bio
The main advantage of trading using opposite Coya Therapeutics, and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |